SCHEMBL29799896

SCHEMBL29799896

CCOC(=O)c1c(N(Cc2ccc(C)cc2)C(C)=O)sc2cc(O)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 2/20 0.42
▸ ALOX5 P09917 3/20 0.40
▸ GAA P10253 4/20 0.39
▸ MAPT P10636 3/20 0.39
▸ POLB P06746 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ MCOLN3 Q8TDD5 1/20 0.39
▸ TRPM8 Q7Z2W7 1/20 0.38
▸ AKR1B1 P15121 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ PKM P14618 2/20 0.37
▸ ESR2 Q92731 1/20 0.37
▸ TSPO P30536 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24682960 1.00 ESR1 (0.42) ESR1ALOX5GAAMAPTPOLB
SCHEMBL24682966 0.92 ALOX5 (0.47) ALOX5GAAMAPTLMNATRPM8
SCHEMBL29799882 0.92 ALOX5 (0.47) ALOX5GAAMAPTLMNATRPM8
SCHEMBL29800048 0.92 LMNA (0.45) ALOX5GAAMAPTMEN1KMT2A
SCHEMBL24683154 0.92 LMNA (0.45) ALOX5GAAMAPTMEN1KMT2A
SCHEMBL24683189 0.91 ESR1 (0.43) ESR1ALOX5GAAMAPTKDM4E
SCHEMBL29799959 0.91 ESR1 (0.43) ESR1ALOX5GAAMAPTKDM4E
SCHEMBL24682822 0.82 ALOX5 (0.48) ALOX5GAAMAPTMEN1KMT2A
SCHEMBL29799819 0.82 ALOX5 (0.48) ALOX5GAAMAPTMEN1KMT2A
SCHEMBL24683210 0.81 ESR1 (0.39) ESR1MAPTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY OTCPHARM JSC (RU) 2024-05-30 — — US disclosed
EP-4293017-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Otcpharm JSC (RU) 2023-12-20 — — EP disclosed
CN-117222630-A 2-acetamido-6-hydroxy-benzothiophene derivatives having antiviral activity OTC制药公司(JSC) 2023-12-12 — — CN disclosed
WO-2022173329-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Акционерное общество "Отисифарм" 2022-08-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY ACE2, ACE, EIF2AK2 ESR1 4305/4885ALOX5 1614/4885GAA 798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback